Cargando…

Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis

Hypoxia inducible factor (HIF)-prolyl hydroxylase (PHD) inhibitors are shown to be protective in several models of inflammatory bowel disease (IBD). However, these non-selective inhibitors are known to inhibit all the three isoforms of PHD, i.e. PHD-1, PHD-2 and PHD-3. In the present report, we inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakshi, Hamid A., Mishra, Vijay, Satija, Saurabh, Mehta, Meenu, Hakkim, Faruk L., Kesharwani, Prashant, Dua, Kamal, Chellappan, Dinesh K., Charbe, Nitin B., Shrivastava, Garima, Rajeshkumar, S., Aljabali, Alaa A., Al-Trad, Bahaa, Pabreja, Kavita, Tambuwala, Murtaza M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856031/ https://www.ncbi.nlm.nih.gov/pubmed/31377947 http://dx.doi.org/10.1007/s10753-019-01065-3

Ejemplares similares

Small interfering RNA for cancer treatment: overcoming hurdles in delivery
por: Charbe, Nitin Bharat, et al.
Publicado: (2020)

Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α
por: A. A. Aljabali, Alaa, et al.
Publicado: (2020)

Correction: Aljabali, A.A.A.; et al. Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer via down Regulation of Nuclear p65 and HIF-1α. Cancers 2020, 12, 113
por: Aljabali, Alaa A. A., et al.
Publicado: (2020)

Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative Damage
por: Bakshi, Hamid A., et al.
Publicado: (2020)

An overview of vaccine development for COVID-19
por: Shahcheraghi, Seyed H, et al.
Publicado: (2021)

Three-dimensional bio-printing: A new frontier in oncology research
por: Charbe, Nitin, et al.
Publicado: (2017)

Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy
por: Alomari, Ghada, et al.
Publicado: (2019)

Circadian Rhythm Disruption and Alzheimer’s Disease: The Dynamics of a Vicious Cycle
por: Sharma, Ashish, et al.
Publicado: (2021)

Biomedical applications of three‐dimensional bioprinted craniofacial tissue engineering
por: Charbe, Nitin Bharat, et al.
Publicado: (2022)

Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases
por: Dhanjal, Daljeet Singh, et al.
Publicado: (2022)

Molecular and cellular effects of gold nanoparticles treatment in experimental diabetic myopathy
por: Al-Shwaheen, Aseel, et al.
Publicado: (2022)

Biosynthesis of gold nanoparticles using leaf extract of Dittrichia viscosa and in vivo assessment of its anti-diabetic efficacy
por: Ayyoub, Sanaa, et al.
Publicado: (2022)

The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010)

Function and expression of prolyl hydroxylase 3 in cancers
por: Liu, Qiu-long, et al.
Publicado: (2013)

Vesicular drug-delivery systems as theranostics in COVID-19
por: Satija, Saurabh, et al.
Publicado: (2020)

Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma
por: Gull, Nighat, et al.
Publicado: (2022)

Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective
por: Prasher, Parteek, et al.
Publicado: (2020)

Application of three-dimensional printing for colon targeted drug delivery systems
por: Charbe, Nitin B., et al.
Publicado: (2017)

Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin‐induced type 1 diabetes in rats
por: Alomari, Ghada, et al.
Publicado: (2021)

Fourth‐generation glucose sensors composed of copper nanostructures for diabetes management: A critical review
por: Naikoo, Gowhar A., et al.
Publicado: (2021)

Structure and Mechanism of a Viral Collagen Prolyl Hydroxylase
por: Longbotham, James E., et al.
Publicado: (2015)

Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
por: Figg, William D., et al.
Publicado: (2021)

Role of prolyl hydroxylase domain proteins in bone metabolism
por: Wolf, David, et al.
Publicado: (2022)

Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases
por: Mehta, Meenu, et al.
Publicado: (2020)

Prolyl 4 Hydroxylase: A Critical Target in the Pathophysiology of Diseases
por: Kant, Ravi, et al.
Publicado: (2013)

The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma
por: Hatzimichael, E, et al.
Publicado: (2012)

Prolyl-hydroxylase 3: evolving roles for an ancient signaling protein
por: Place, Trenton L, et al.
Publicado: (2013)

Role of prolyl hydroxylase domain proteins in the regulation of insulin secretion
por: Huang, Mei, et al.
Publicado: (2016)

Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
por: Yang, Ming, et al.
Publicado: (2014)

Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
por: Yum, Soohwan, et al.
Publicado: (2017)

An Arabidopsis Prolyl 4 Hydroxylase Is Involved in the Low Oxygen Response
por: Konkina, Anna, et al.
Publicado: (2021)

Prolyl 3-Hydroxylase 2 Is a Molecular Player of Angiogenesis
por: Pignata, Paola, et al.
Publicado: (2021)

Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor
por: Wang, Ruth X., et al.
Publicado: (2021)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
por: Strowitzki, Moritz J., et al.
Publicado: (2021)

Role of prolyl hydroxylase/HIF-1 signaling in vascular calcification
por: Negri, Armando Luis
Publicado: (2022)

Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular risk
por: Harlow, Charli E, et al.
Publicado: (2022)

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
por: Ogawa, Chie, et al.
Publicado: (2023)

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
por: Lun, Jie, et al.
Publicado: (2023)

Impact of exosome therapy on pancreatic cancer and its progression
por: El-Tanani, Mohamed, et al.
Publicado: (2023)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
por: Kiriakidis, Serafim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sr7q1kod70bq4ajcqjhs1n3gja